Access to continuous glucose monitors (CGM) can be severely limited. Tamara Oser, a researcher at the University of Colorado, launched PREPARE 4 CGM, a project to...

diaTribe’s own Diane Scherer shares why she is both eager and hesitant as she navigates various diabetes devices over the years and offers tips for trying new technology.

Dexcom and Division I college athletes have teamed up to encourage other people living with diabetes to fully participate in sports.

The FDA approved Proclaim XR, a new implantable spinal cord stimulation device, as a treatment for pain from diabetes-related nerve damage, which affects 1 in 3 people...

The FDA cleared Tidepool Loop for people with type 1 diabetes ages six and up. Tidepool Loop is now the first “do-it-yourself” automated insulin delivery system with...

New study results showed that using an artificial pancreas, or fully closed-loop automated insulin delivery system, improved time spent in a healthy glucose range by...

A health benefits program for uninsured individuals expanded eligibility for coverage of the Dexcom G6 continuous glucose monitor (CGM) to all people with type 1...

The FDA cleared Mallya, a new smart medical device for disposable injector pens. This allows users of both insulin and GLP-1 receptor agonist pens to connect the device...

The Extended infusion set doubles the amount of wear time from previous models and allows for changing the reservoir mid-way through use. Additionally, the new design...

Over the past year, there have been tremendous advances in technology that aim to help people manage their diabetes. Here are some highlights of the major developments...

The long-awaited FDA clearance of Dexcom G7 is finally here! G7 improves on Dexcom’s current continuous glucose monitoring (CGM) system, the G6, with greater accuracy,...

At the DiabetesMine Fall Innovation Summit, medical device manufacturers, patient entrepreneurs, and innovators gathered in San Francisco to display the latest...

Technology has improved insulin delivery devices, which has made managing glucose levels easier. Yet most people who take insulin continue to use a syringe or...

A study recently published in the New England Journal of Medicine shows that a bionic pancreas, or a closed-loop automated insulin delivery system, kept blood glucose...

The first large-scale launch of the highly anticipated Dexcom G7 continuous glucose monitor (CGM) has officially begun. The next-generation CGM is now available in...

Managing your Time in Range (TIR) can be challenging, but there are several apps you can download to help you. In this article, we cover 14 apps you may want to check...

Continuous glucose monitors (CGM) are a valuable tool, allowing people with diabetes to stay informed to make decisions without having to constantly prick their fingers...

A fascinating session at the EASD 2022 conference on emerging technologies sheds light on where we are with AID and telemedicine, and what leading researchers in...

A recent research study on open-source AID, a method of insulin delivery used by thousands of people with type 1 diabetes, showed that using open-source AID improved...

Impressive results from a trial for an up-and-coming artificial pancreas showed that users spent an average of 2.6 more hours in range each day compared to non-users –...